Parkwalk have recently closed an investment in Fluidic Analytics for the University of Cambridge Enterprise Fund IV and Parkwalk Funds.
Fluidic Analytics is developing a line of tools for the rapid, accurate, cost-effective analysis of proteins and other biomolecular species. By combining a powerful microfluidics platform developed at the University of Cambridge with efficient manufacturing and design principles, the Company is striving to be a leading provider of products that enable breakthrough advances in fundamental protein science, drug development and diagnostics.
By developing products that make protein characterisation faster, more precise, more convenient, more cost-effective and more accurate, Fluidic Analytics is striving to help scientists, healthcare providers and people everywhere to understand the world around them better.
More detail can be seen on the company’s website here.